Senex Biotechnology
Dani P. Bolognesi, PhD., Director. Dr. Bolognesi is Professor Emeritus at Duke University, is Founder, CEO and CSO at Trimeris, Inc., a public company that developed Fuzeon®, a first-in-class HIV fusion inhibitor, in collaboration with Hoffmann-La Roche. He is also CEO and Chairman of b3Bio, Inc; CEO, Enci Therapeutics, Inc., CEO at C2 Regenerate, Inc and CSO of Istari Oncology, Inc.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Senex Biotechnology
Senex Biotechnology is engaged in discovering and developing therapeutic agents to treat cancer, viral diseases, and age-related diseases.